Molecular studies in patients with chronic myeloid leukaemia in remission 5 years after allogeneic stem cell transplant define the risk of subsequent relapse-Reference-Cited by-同舟云学术

Molecular studies in patients with chronic myeloid leukaemia in remission 5 years after allogeneic stem cell transplant define the risk of subsequent relapse

Published:2001-12 Issue:3 Volume:115 Page:569-574
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Mughal Tariq I.,Yong Agnes,Szydlo Richard M.,Dazzi Francesco,Olavarria Eduardo,Van Rhee Frits,Kaeda Jaspal,Cross Nick C. P.,Craddock Charles,Kanfer Ed,Apperley Jane,Goldman John M.

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2141.2001.03155.x/fullpdf

Reference28 articles.

1. Donor leukocyte infusions in 140 patients with relapse malignancy after allogeneic bone marrow transplantation;Collins;Journal of Clinical Oncology,1997

2. Minimal residual disease after allogeneic bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: correlations with acute graft-versus-host disease and relapse;Cross;British Journal of Haematology,1993a

3. Competitive polymerase chain reaction to estimate the number of BCR-ABL transcripts in chronic myeloid leukemia after bone marrow transplantation;Cross;Blood,1993b

4. An optimised multiplex polymerase chain reaction for detection of BCR-ABL fusion mRNAs in haematological disorders;Cross;Leukemia,1994

5. Durability of responses following donor lymphocyte infusions for patients who relapse after allografting for chronic myeloid leukemia;Dazzi;Blood,2000a

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Extramedullary Relapse in a CML Patient after Allogeneic Stem Cell Transplantation;CASE REP HEMATOL;2017

2. Chronic myeloid leukemia: reminiscences and dreams;Haematologica;2016-04-30

3. The Detection and Significance of Minimal Residual Disease;Thomas’ Hematopoietic Cell Transplantation;2016-01-01

4. Discontinuation of Therapy and Treatment-Free Remission in CML;Molecular Pathogenesis and Treatment of Chronic Myelogenous Leukemia;2016

5. Evaluation of a novel multiplex RT-qPCR assay for the quantification of leukemia-associated BCR-ABL1 translocation;International Journal of Hematology;2015-08-05